TOP STORIES

• REGULATORY Japan Inks Supply Deal for Shionogi’s COVID Pill for 1 Million People
  March 25, 2022

• REGULATORY Japan Panel Agrees to Prep for Fourth Shot, but Wants Cautious Approach; Free Booster OK’ed for Ages 12-17
  March 25, 2022

• REGULATORY Enhertu Braced for Price Cuts as Chuikyo OKs CEA Results; Evrysdi Not Subject to Scheme
  March 24, 2022

• REGULATORY Pfizer COVID Booster OK’ed for Ages 12-17, Comirnaty Label Revised
  March 24, 2022

• REGULATORY Kyowa Pharma to Face Biz Suspension Order over Manufacturing Flaws
  March 23, 2022

• REGULATORY AMED’s SCARDA Boots Up as Command Tower for Vaccine Development
  March 23, 2022

• ORGANIZATION Number of MSLs Tops 1,000 in FY2021, Up 50% in 2 Years; Lack of Talent an Obstacle to Further Growth: JAPhMed
  March 22, 2022

• BUSINESS Sanofi Files PD-1 Drug Cemiplimab for Cervical Cancer in Japan
  March 22, 2022

• BUSINESS Generic Makers, PMDA Exploring GMP Inspection Methods for Overseas Sites; Onsite Checks Not Possible for 2 Years
  March 18, 2022

• REGULATORY MHLW Panel to Discuss Pfizer COVID Booster for Ages 12-17
  March 18, 2022

• BUSINESS Aduhelm Deal Revised, Eisai Poised to Sharpen Focus on Lecanemab: CEO
  March 17, 2022

• COMMENTARY Drug Makers Guard against Price Adjustment Rate, Off-Year Revision Debates: Jiho Poll
  March 16, 2022

• BUSINESS Biogen/Eisai Alzheimer’s Pact Amended to Switch Aducanumab Collab to Royalty Scheme
  March 16, 2022

• ORGANIZATION API Import Costs from Europe Surging amid Russian Airspace Closures
  March 15, 2022

• ORGANIZATION List of 180 Needed Drugs Compiled in Europe-Led Drive to Support Ukraine
  March 14, 2022

• BUSINESS Moderna Accelerating Bivalent Vaccine Development for 4th COVID Shot: Japan Chief
  March 14, 2022

• BUSINESS Fujifilm Drops Avigan’s Japan PIII Trial for COVID-19
  March 14, 2022

• BUSINESS Authorized Generics Likely Speeding Up G1/G2 Price Cuts for Off-Patent Brands: Jiho Tally
  March 11, 2022

• BUSINESS Chugai Won’t Challenge Edirol Substance Patent Ruling
  March 11, 2022

• REGULATORY Panel Confirms Backing for Alexion’s Bleeding Antidote after Data Integrity Issues
  March 10, 2022

ページ

• « 先頭
• ‹ Prev
• …
• 75
• 76
• 77
• 78
• 79
• 80
• 81
• 82
• 83
• …
• Next ›
• 最終 »